Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Lyra Therapeutics (LYRA) Non-cash Items (2021 - 2025)

Lyra Therapeutics has reported Non-cash Items over the past 5 years, most recently at $52210.0 for Q4 2025.

  • Quarterly results put Non-cash Items at $52210.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $52210.0 (changed N/A YoY), and the annual figure for FY2025 was $52210.0, down 98.15%.
  • Non-cash Items for Q4 2025 was $52210.0 at Lyra Therapeutics, down from $1.3 million in the prior quarter.
  • Over the last five years, Non-cash Items for LYRA hit a ceiling of $12.9 million in Q1 2024 and a floor of $52210.0 in Q4 2025.
  • Median Non-cash Items over the past 5 years was $1.3 million (2024), compared with a mean of $2.5 million.
  • Biggest five-year swings in Non-cash Items: crashed 92.55% in 2023 and later surged 22480.7% in 2024.
  • Lyra Therapeutics' Non-cash Items stood at $918000.0 in 2021, then crashed by 58.82% to $378000.0 in 2022, then soared by 1575.66% to $6.3 million in 2023, then plummeted by 79.48% to $1.3 million in 2024, then tumbled by 95.98% to $52210.0 in 2025.
  • The last three reported values for Non-cash Items were $52210.0 (Q4 2025), $1.3 million (Q3 2024), and $1.4 million (Q2 2024) per Business Quant data.